ARP Is Still Compelling, Recovery Predicted By Year-End
Jun 9, 2022
Alternative risk premia strategies have been plagued with disappointing returns over the last few years, forcing many — but not all — investors to question the strategy’s place in the market. But a recovery is well on the way with positive returns seen across many alternative strategies, according to market observers. EQDerivatives’ Georgia Reynolds spoke with bfinance’s Toby Goodworth, BBVA’s Laura de Frutos Sastre and Unigestion’s Joan Lee, to get the run down on the strategy’s apparent rebound.
Restricted content
You must be an EQD+ subscriber to view this page. Either sign in or see below on how to request a trial.
Get access now
Start your 7 day free trial.
You’ll be charged at the conclusion of your trial.
Cancel at any time.
Questions? Need access for multiple users?
Contact eqdplus@eqderivatives.com